Schedule 13D ownership disclosure

PEREGRINE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 713661304

Event date: 2017-10-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,310,652
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-061795
Form type
SC 13D/A
Filer
Avid Bioservices, Inc.
CIK
CIK 704562
Filed
Oct 11, 2017
Reporting period
Oct 09, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub